VERSION 1 -REVIEW

REVIEWER
Omid Mehrpour Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Moallem Avenue, Birjand,Iran REVIEW RETURNED 07-Feb-2018
GENERAL COMMENTS
Thanks for revision of the manuscript. I am much in line with the revised manuscript. And now it looks much clearer and well organized.
REVIEWER
Pablo Enrique Chaparro Narváez Instituto Nacional de Salud. Colombia REVIEW RETURNED 22-Feb-2018
GENERAL COMMENTS
Thanks, the suggestions were welcomed
VERSION 1 -AUTHOR RESPONSE
List of changes 1) Strengths and limitations part has been revised with revised five bullet points (see Page 3 'Strengths and limitations' section ) 2)
Patient involvement part has been included in the method section (see page 9 'patient involvement' section)
Point-to-Point response to editor and reviewers' commons are as followed: Editor comment to author: (1) Please ensure that you update the trial registry record in order to reflect the modifications made to your trial and provide consistent information with your protocol article. For example, please update the sample size in the registry. Answer: The registry has been updated according to the revised protocol on clinicaltrials.gov, which can be searched with registration number NCT03314909.
We have updated the sample size, outcomes, statistical analysis plan, etc. All modifications have been reflected in the updated record.
(2) Please revise the 'Strengths and limitations' section of your manuscript (after the abstract). This section should contain five short bullet points, no longer than one sentence each, that relate specifically to the methods. Answer: We have revised our 'strengths and limitations' section with five short bullet points, see page 3 line 2. 
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